Emmanouil Metzakopian
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Correction: Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.
Journal: Molecular neurodegeneration
Published: March 26, 2024
Genome-wide CRISPR/Cas9 screen shows that loss of GET4 increases mitochondria-endoplasmic reticulum contact sites and is neuroprotective.
Journal: Cell death & disease
Published: June 26, 2023
Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.
Journal: Molecular neurodegeneration
Published: May 16, 2023
Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
Journal: Neuroscience research
Published: April 03, 2023
CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.
Journal: Scientific reports
Published: December 11, 2022
HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.
Journal: The EMBO journal
Published: November 29, 2022
Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson's Disease Independent of Mutations in MAPT.
Journal: Metabolites
Published: November 01, 2022
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Journal: Nature genetics
Published: June 14, 2022
Derivation of nociceptive sensory neurons from hiPSCs with early patterning and temporally controlled NEUROG2 overexpression.
Journal: Cell reports methods
Published: November 10, 2021
Last Updated: 09/26/2026